#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hodgkin's disease refractory Cholestatic pruritus Pyruvate kinase deficiency anaemia Infective uveitis Medullary thyroid cancer Mantle cell lymphoma recurrent Leiomyosarcoma Thrombocytopenia Breast cancer metastatic Atypical haemolytic uraemic syndrome Diabetes insipidus Duchenne muscular dystrophy gene carrier Adrenoleukodystrophy Pulmonary sarcoidosis Anti-HLA antibody test positive More trials…

    Learn about Rare Diseases

    Wolfram syndrome – Life with Disease Glomerulonephritis membranous – Trials in Disease Alveolar rhabdomyosarcoma – Trials in Disease Focal segmental glomerulosclerosis – Life with Disease Cholangitis sclerosing Angiosarcoma non-metastatic Congenital nephrogenic diabetes insipidus – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Mucous membrane pemphigoid – Treatment Skin angiosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sorafenib Tosilate DCC-3084 COLESEVELAM HYDROCHLORIDE Pyridoxine Hydrochloride VERCIRNON Salbutamol Mb-Cart20.1 Sodium Chloride Omp10 Fludrocortisone Ecopipam Hydrochloride 64Cu-Dota-Ae105 Edg-5506 Dorzolamide Hydrochloride Cortisone Acetate GSK5460025A Silibinin Ribonucleic Acid K30 ALN-961583 Gsk4527226 More therapies…

    Learn about Your Condition

    Latent tuberculosis Hepatitis B Erdheim-Chester disease Vascular malformation Acute myeloid leukaemia Procedural anxiety Narcolepsy Impaired gastric emptying Implantation complication Idiopathic pulmonary fibrosis Embolism Peritoneal abscess Retinopathy proliferative Retinitis pigmentosa Inborn error of metabolism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study on GSK3858279 for Adults with Moderate to Severe Knee Osteoarthritis Pain

    Not recruiting

    2 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Gsk3858279
    France Germany Spain

  • Study on AOC 1020 for Adults with Facioscapulohumeral Muscular Dystrophy (FSHD)

    Not recruiting

    2 1
    Investigated Diseases:
    • Facioscapulohumeral muscular dystrophy
    Investigated Drugs:
    • Humanised Igg1 Monoclonal Antibody Against Tfr1 Conjugated To Double Stranded Sirna Oligonucleotide Against Dux4 Mrna Via A Non-Cleavable Linker
    Italy The Netherlands

  • Study of LY3871801 for Adults with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    2 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Ly3871801
    Czechia France Germany Hungary Poland Slovakia

  • Study on the Effectiveness and Safety of Secukinumab for Adults with Moderate to Severe Rotator Cuff Tendinopathy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Secukinumab
    Bulgaria Czechia Denmark France Portugal Slovakia

  • Study Comparing Setrusumab and Bisphosphonates for Children with Osteogenesis Imperfecta

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteogenesis imperfecta
    Investigated Drugs:
    • Neridronate Sodium
    • Pamidronate Disodium
    • Setrusumab
    France Germany Italy The Netherlands Poland

  • Clonidine Hydrochloride for Pain Management After Spine Surgery in Patients with Degenerative Spine Diseases

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Sodium Chloride
    • Clonidine Hydrochloride
    Denmark
Previous Page
1 … 63 64 65 66 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!